A Multicenter, Retrospective Analysis of Long-Term Survival in 255 Dogs With Pheochromocytoma Treated With Alpha-Adrenoreceptor Antagonists or Surgery (2010–2021)
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.70220 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Matthew M E Steele und 39 weiteren Autor:innen. Beteiligte Einrichtung: ChesterGates Veterinary Specialists, Chester, UK. Hauptthemen laut MEDLINE: Pheochromocytoma, Dog Diseases, Adrenal Gland Neoplasms, Adrenalectomy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Small Animal Medicine Society.
Abstract (Originalsprache)
Background
The survival of dogs with pheochromocytoma (PCC) treated with adrenoreceptor antagonists has not been described or compared to surgically managed cases. Hypothesis/Objectives The objective of this study is to evaluate the survival of medically and surgically managed dogs with PCC and investigate factors associated with survival. Animals Two hundred fifty-five dogs with PCC, treated with alpha-adrenoreceptor antagonists (AA) without adrenalectomy (Group 1, n = 75), adrenalectomy +/– AA (Group 2, n = 128), or neither treatment (Group 3, n = 52).
Methods
Retrospective, multicenter review of medical records. Median overall survival time (OST) for Groups 1 and 2 combined was calculated using Kaplan–Meier estimates, and then compared between Group 1 and Group 2 using Log-Rank testing. Cox proportional hazard analysis identified factors associated with survival in Groups 1 and 2 individually and combined.
Results
Median OST for all cases was 854 (95% CI: 572–1136) days. Median OST was lower in Group 1 (247 days, 95% CI: 76–418 days) than in Group 2 (927 days, 95% CI: 587–1267 days; p < 0.001). In Group 2, 88/92 dogs (97.8%) that received presurgical AA treatment survived to discharge compared to 23/27 (85.2%) that did not receive AA pretreatment (p = 0.03). Lack of clinical signs at presentation was associated with increased survival in both groups combined (HR 0.5; 95% CI 0.3–0.9; p = 0.02) and in Group 2 alone (HR 0.3; 95% CI 0.1–0.7; p = 0.01). Conclusions and Clinical Importance Dogs with PCC treated with adrenalectomy have longer survival compared to those managed with AA without adrenalectomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ChesterGates Veterinary Specialists, Chester, UK.
- Clinical Science and Services, Royal Veterinary College, London, UK.
- Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
- Davies Veterinary Specialists, Hitchin, UK.
- Anderson Moores Veterinary Specialists, Winchester, UK.
- The Queens Veterinary School Hospital, University of Cambridge, Cambridge, UK.
ORCID-Profile: Matthew M E Steele, Marit F van den Berg, Sara Galac, Nadja Sieber-Ruckstuhl, Ghita Benchekroun, Alisdair Boag, Federico Fracassi, Alejandra Carranza Valencia, Jorge Pena-Ramos, Romy M Heilmann, Paolo Silverstrini, Carolina Arenas, Mario Cervone, Rodolfo O Leal, Anaïs Lamoureux, Ruth Gostelow
Förderung
- Small Animal Medicine Society
Zitieren
APA
Steele, M. M. E., van den Berg, M. F., Galac, S., Dordio, A. M., Threlfall, A., Gomes, C., Paul, A., Nolff, M., Sieber-Ruckstuhl, N., Benchekroun, G., Allerton, F., Mendoza, B., Spence, S., Valiente, P., Boag, A., Fracassi, F., Carranza Valencia, A., Pena-Ramos, J., Lloyd-Bradley, B., …, & Gostelow, R. (2025). A Multicenter, Retrospective Analysis of Long-Term Survival in 255 Dogs With Pheochromocytoma Treated With Alpha-Adrenoreceptor Antagonists or Surgery (2010–2021). Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70220
Vancouver
Steele MME, van den Berg MF, Galac S, Dordio AM, Threlfall A, Gomes C, et al. A Multicenter, Retrospective Analysis of Long-Term Survival in 255 Dogs With Pheochromocytoma Treated With Alpha-Adrenoreceptor Antagonists or Surgery (2010–2021). Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70220
BibTeX
@article{Steele2025,
author = {Steele, Matthew M E and van den Berg, Marit F and Galac, Sara and Dordio, Ana M and Threlfall, Anna and Gomes, Cláudia and Paul, Amanda and Nolff, Mirja and Sieber-Ruckstuhl, Nadja and Benchekroun, Ghita and Allerton, Fergus and Mendoza, Beatriz and Spence, Susanna and Valiente, Paula and Boag, Alisdair and Fracassi, Federico and Carranza Valencia, Alejandra and Pena-Ramos, Jorge and Lloyd-Bradley, Ben and Seth, Mayank and Fawsitt, Jack and Yu Foo, Fang and Heilmann, Romy M and Silverstrini, Paolo and Lyssens, Aurélie and Vangrinsven, Emilie and Casas-Acuna, Clara and Hrovat, Alenka and Arenas, Carolina and Cervone, Mario and Mooney, Carmel T and Leal, Rodolfo O and Piekos, Karolina Maria and Olivares, Gerard and Ruiz, Guillame and Caulfield, Sarah J and Keyte, Sophie and Lamoureux, Anaïs and Scudder, Christopher J and Gostelow, Ruth},
title = {A Multicenter, Retrospective Analysis of Long-Term Survival in 255 Dogs With Pheochromocytoma Treated With Alpha-Adrenoreceptor Antagonists or Surgery (2010–2021)},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.70220}
}
EUVIMED